Zhang L, et al. - In China, patients with confirmed diagnoses of ankylosing spondylitis (AS), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE) were recruited to determine treatment adherence and disease burden, analyze detailed medication problems experienced by them and identify factors associated with adherence. Overall, rheumatic disease patients here indicated adherence rate of 41.7%, which was lower than in many other parts of the world. Thereby suggesting the significance of identifying methods that improve adherence in this population. It is particularly important to improve the health status and reduce the disease burden of patients with SLE, the most common of the three rheumatic diseases they analyzed. Results suggested the utility of reminder tools in improving adherence.